189 related articles for article (PubMed ID: 9191002)
1. Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival.
Gansler TS; Hardman W; Hunt DA; Schaffel S; Hennigar RA
Hum Pathol; 1997 Jun; 28(6):686-92. PubMed ID: 9191002
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer.
Shurbaji MS; Kalbfleisch JH; Thurmond TS
Hum Pathol; 1996 Sep; 27(9):917-21. PubMed ID: 8816886
[TBL] [Abstract][Full Text] [Related]
3. Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study.
Davidson B; Gotlieb WH; Ben-Baruch G; Kopolovic J; Goldberg I; Nesland JM; Berner A; Bjåmer A; Bryne M
Gynecol Oncol; 2000 Apr; 77(1):35-43. PubMed ID: 10739688
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor.
Zhao C; Bratthauer GL; Barner R; Vang R
Am J Surg Pathol; 2007 Sep; 31(9):1378-86. PubMed ID: 17721194
[TBL] [Abstract][Full Text] [Related]
5. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
6. CD34 immunohistochemistry in female genital tract carcinosarcoma (malignant mixed müllerian tumors) supports a dominant role of the carcinomatous component.
Costa MJ; Guinee D
Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):293-9. PubMed ID: 11127921
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
8. B7-H4 overexpression in ovarian tumors.
Tringler B; Liu W; Corral L; Torkko KC; Enomoto T; Davidson S; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical characterization of mullerian mucinous borderline tumors: possible histogenetic link with serous borderline tumors and low-grade endometrioid tumors.
Yasunaga M; Ohishi Y; Oda Y; Misumi M; Iwasa A; Kurihara S; Nishimura I; Okuma E; Kobayashi H; Wake N; Tsuneyoshi M
Hum Pathol; 2009 Jul; 40(7):965-74. PubMed ID: 19269675
[TBL] [Abstract][Full Text] [Related]
10. CD56 (Neural Cell Adhesion Molecule) Expression in Ovarian Carcinomas: Association With High-Grade and Advanced Stage But Not With Neuroendocrine Differentiation.
Bösmüller HC; Wagner P; Pham DL; Fischer AK; Greif K; Beschorner C; Sipos B; Fend F; Staebler A
Int J Gynecol Cancer; 2017 Feb; 27(2):239-245. PubMed ID: 27984374
[TBL] [Abstract][Full Text] [Related]
11. PTK7 protein is decreased in epithelial ovarian carcinomas with poor prognosis.
Wang H; Li G; Yin Y; Wang J; Wang H; Wei W; Guo Q; Ma H; Shi Q; Zhou X; Wang J
Int J Clin Exp Pathol; 2014; 7(11):7881-9. PubMed ID: 25550828
[TBL] [Abstract][Full Text] [Related]
12. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma.
Djordjevic B; Malpica A
Am J Surg Pathol; 2012 Jul; 36(7):955-63. PubMed ID: 22613998
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of fatty acid synthase in ovarian neoplasms.
Alò PL; Visca P; Framarino ML; Botti C; Monaco S; Sebastiani V; Serpieri DE; Di Tondo U
Oncol Rep; 2000; 7(6):1383-8. PubMed ID: 11032949
[TBL] [Abstract][Full Text] [Related]
14. Fatty acid synthase is highly expressed in carcinoma, adenoma and in regenerative epithelium and intestinal metaplasia of the stomach.
Kusakabe T; Nashimoto A; Honma K; Suzuki T
Histopathology; 2002 Jan; 40(1):71-9. PubMed ID: 11903600
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
16. Presence of a sarcomatous component outside the ovary is an adverse prognostic factor for primary ovarian malignant mixed mesodermal/mullerian tumors: a clinicopathologic study of 47 cases.
Kunkel J; Peng Y; Tao Y; Krigman H; Cao D
Am J Surg Pathol; 2012 Jun; 36(6):831-7. PubMed ID: 22588065
[TBL] [Abstract][Full Text] [Related]
17. Expressions of Fas ligand and other apoptosis-related genes and their prognostic significance in epithelial ovarian neoplasms.
Munakata S; Enomoto T; Tsujimoto M; Otsuki Y; Miwa H; Kanno H; Aozasa K
Br J Cancer; 2000 Apr; 82(8):1446-52. PubMed ID: 10780525
[TBL] [Abstract][Full Text] [Related]
18. Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study.
Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Christensen IJ; Gayther S; Jacobs IJ; Høgdall CK
Gynecol Oncol; 2007 Aug; 106(2):318-24. PubMed ID: 17540436
[TBL] [Abstract][Full Text] [Related]
19. [An immunohistochemical study of intestinal mucinous antigens and CEA in ovarian epithelial tumors].
Liu A; Wang M; Li H
Zhonghua Bing Li Xue Za Zhi; 1995 Dec; 24(6):366-8. PubMed ID: 8732094
[TBL] [Abstract][Full Text] [Related]
20. Sox10 expression in ovarian epithelial tumors is associated with poor overall survival.
Kwon AY; Heo I; Lee HJ; Kim G; Kang H; Heo JH; Kim TH; An HJ
Virchows Arch; 2016 May; 468(5):597-605. PubMed ID: 26951260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]